Simon Douglas

Chairman of the Board
Immunology
AAREY DRUGS & PHARMACEUTICALS LTD
United Kingdom

Business Expert Infectious Diseases
Biography

 Simon's experience in the Biotech industry includes 5 years working for Amersham International, ICI and Zeneca, in a variety of commercial and technical positions, and over 5 years with an LSE listed diagnostic company where he was the Chief Executive and raised £10 million as a rights issue. Most recently he was CEO of the embryonic start up company DNA Research Innovations Ltd (DRI) growing the company during 4 years and completing two rounds of Venture Capital financing. In November 2004, under his leadership, DRI was aquired by the Invitrogen Corporation for $65 million

Research Intrest

 DNA Research , Biotech